• Molecular NameN-acetylprocainamide
  • SynonymNA
  • Weight277.368
  • Drugbank_IDN/A
  • ACS_NO32795-44-1
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)1.27
  • pkaN/A
  • LogD (pH=7, predicted)-0.88
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.51
  • LogSw (predicted, AB/LogsW2.0)7.88
  • Sw (mg/ml) (predicted, ACD/Labs)5.57
  • No.of HBond Donors2
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds7
  • TPSA61.44
  • StatusN/A
  • AdministrationIntravenously or orally
  • PharmacologyThe N-acetylated metabolite of procainamide. It is a Class III antiarrhythmic agent.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability83.0
  • Protein binding10.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life6~9 h in normal subjects; increased in subjects with heart disease or renal impairment.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A